Authors:
HADDOW JE
PALOMAKI GE
KNIGHT GJ
FOSTER DL
NEVEUX LM
Citation: Je. Haddow et al., 2ND-TRIMESTER SCREENING FOR DOWNS-SYNDROME USING MATERNAL SERUM DIMERIC INHIBIN-A, Journal of medical screening, 5(3), 1998, pp. 115-119
Authors:
HADDOW JE
PALOMAKI GE
KNIGHT GJ
WILLIAMS J
MILLER WA
JOHNSON A
Citation: Je. Haddow et al., SCREENING OF MATERNAL SERUM FOR FETAL DOWNS-SYNDROME IN THE FIRST-TRIMESTER, The New England journal of medicine, 338(14), 1998, pp. 955-961
Authors:
PALOMAKI GE
KNIGHT GJ
MCCARTHY JE
HADDOW JE
DONHOWE JM
Citation: Ge. Palomaki et al., MATERNAL SERUM SCREENING FOR DOWN-SYNDROME IN THE UNITED-STATES - A 1995 SURVEY, American journal of obstetrics and gynecology, 176(5), 1997, pp. 1046-1051
Authors:
PALOMAKI GE
NEVEUX LM
KNIGHT GJ
HADDOW JE
Citation: Ge. Palomaki et al., MATERNAL WEIGHT AND FIRST-TRIMESTER DOWN-SYNDROME SCREENING, American journal of human genetics, 61(4), 1997, pp. 915-915
Authors:
SARNESO CA
ROSENBAUM KN
IRONS MB
KNIGHT GJ
ELIAS ER
Citation: Ca. Sarneso et al., PRENATAL-DIAGNOSIS AND CHOLESTEROL SUPPLEMENTATION IN A PREGNANCY AFFECTED WITH SMITH-LEMLI-OPITZ-SYNDROME, American journal of human genetics, 61(4), 1997, pp. 927-927
Authors:
WALD NJ
KENNARD A
WATTE H
HADDOW JE
PALOMAKI GE
KNIGHT GJ
CANICK JA
Citation: Nj. Wald et al., DECISION-ANALYSIS AND SCREENING FOR DOWNS-SYNDROME - TESTING SHOULD BE IN ALL WOMEN, BMJ. British medical journal, 311(7016), 1995, pp. 1372-1372
Authors:
PALOMAKI GE
HADDOW JE
KNIGHT GJ
WALD NJ
KENNARD A
CANICK JA
SALLER DN
BLITZER MG
DICKERMAN LH
FISHER R
HANSMANN D
HANSMANN M
LUTHY DA
SUMMERS AM
WYATT P
Citation: Ge. Palomaki et al., RISK-BASED PRENATAL SCREENING FOR TRISOMY-18 USING ALPHA-FETOPROTEIN,UNCONJUGATED ESTRIOL AND HUMAN CHORIONIC-GONADOTROPIN, Prenatal diagnosis, 15(8), 1995, pp. 713-723
Authors:
ADAMS MJ
KHOURY MJ
SCANLON KS
STEVENSON RE
KNIGHT GJ
HADDOW JE
SYLVESTER GC
CHEEK JE
HENRY JP
STABLER SP
ALLEN RH
Citation: Mj. Adams et al., ELEVATED MIDTRIMESTER SERUM METHYLMALONIC ACID LEVELS AS A RISK FACTOR FOR NEURAL-TUBE DEFECTS, Teratology, 51(5), 1995, pp. 311-317
Authors:
HAYDE M
POLLAK A
BERNASCHEK G
VREMAN HJ
STEVENSON DK
KNIGHT GJ
HADDOW JE
WEINER CP
WIDNESS JA
Citation: M. Hayde et al., ASSOCIATION OF FETAL AND MATERNAL CARBOXYHEMOGLOBIN LEVELS WITH MATERNAL CIGARETTE-SMOKING, Pediatric research, 37(4), 1995, pp. 138-138
Authors:
ROSE NC
CANICK JA
KNIGHT GJ
PULKKINEN A
TUMBER MB
MENNUTI MT
PALOMAKI GE
Citation: Nc. Rose et al., 2ND-TRIMESTER DIURNAL-VARIATION OF MATERNAL SERUM ALPHA-FETOPROTEIN, HUMAN CHORIONIC-GONADOTROPIN, AND UNCONJUGATED ESTRIOL - IS IT PRESENTAND DOES IT AFFECT THE PREDICTION OF A PATIENTS RISK FOR FETAL DOWN-SYNDROME, Prenatal diagnosis, 14(10), 1994, pp. 947-951
Citation: Ge. Palomaki et al., HUMAN CHORIONIC-GONADOTROPIN AND UNCONJUGATED ESTRIOL MEASUREMENTS ININSULIN-DEPENDENT DIABETIC PREGNANT-WOMEN BEING SCREENED FOR FETAL DOWN-SYNDROME, Prenatal diagnosis, 14(1), 1994, pp. 65-68
Authors:
HADDOW JE
PALOMAKI GE
KNIGHT GJ
CUNNINGHAM GC
LUSTIG LS
BOYD PA
Citation: Je. Haddow et al., REDUCING THE NEED FOR AMNIOCENTESIS IN WOMEN 35 YEARS OF AGE OR OLDERWITH SERUM MARKERS FOR SCREENING, The New England journal of medicine, 330(16), 1994, pp. 1114-1118
Citation: Je. Haddow et al., ANTENATAL SCREENING FOR DOWNS-SYNDROME - PERFORMANCE OF DIFFERENT MARKERS REMAINS CONFUSED, BMJ. British medical journal, 307(6905), 1993, pp. 679-680
Citation: Ge. Palomaki et al., CALCULATING AMNIOTIC-FLUID ALPHA-FETOPROTEIN MEDIAN VALUES IN THE 1STTRIMESTER, Prenatal diagnosis, 13(9), 1993, pp. 887-889
Authors:
PALOMAKI GE
KNIGHT GJ
HADDOW JE
CANICK JA
WALD NJ
KENNARD A
Citation: Ge. Palomaki et al., CIGARETTE-SMOKING AND LEVELS OF MATERNAL SERUM ALPHA-FETOPROTEIN, UNCONJUGATED ESTRIOL, AND HCG - IMPACT ON DOWN-SYNDROME SCREENING, Obstetrics and gynecology, 81(5), 1993, pp. 675-678